Opus Genetics, Inc. Depreciation
Opus Genetics, Inc. (IRD) reported Depreciation of $27.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- Opus Genetics, Inc. depreciation for the quarter ending 2026-06-30 was $14.00K, a 0.00% change year-over-year.
- Opus Genetics, Inc. depreciation for the quarter ending 2026-03-31 was $13.00K, a 0.00% change year-over-year.
- Opus Genetics, Inc. depreciation for the quarter ending 2025-12-31 was $13.00K, a 30.00% increase year-over-year.
- Opus Genetics, Inc. depreciation for the quarter ending 2025-09-30 was $13.00K.
- Opus Genetics, Inc. depreciation for fiscal 2025 was $53.00K, a 430.00% increase from fiscal 2024.
- Opus Genetics, Inc. depreciation for fiscal 2024 was $10.00K, a 66.67% increase from fiscal 2023.
- Opus Genetics, Inc. depreciation for fiscal 2023 was $6.00K, a 50.00% increase from fiscal 2022.
- Opus Genetics, Inc. depreciation for fiscal 2022 was $4.00K, a 0.00% change from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $27.00K 10-Q · filed 2026-08-06 | $40.00K derived: sum of 3 quarters · filed 2026-08-06 | $53.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $13.00K 10-Q · filed 2026-05-12 | $26.00K derived: sum of 2 quarters · filed 2026-05-12 | $39.00K derived: sum of 3 quarters · filed 2026-05-12 | $53.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $26.00K derived: sum of 2 quarters · filed 2026-03-12 | $40.00K derived: sum of 3 quarters · filed 2026-08-06 | $53.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $27.00K derived: sum of 2 quarters · filed 2026-08-06 | $40.00K 10-Q · filed 2025-11-12 | $50.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $27.00K 10-Q · filed 2026-08-06 | $37.00K derived: sum of 3 quarters · filed 2026-08-06 | $37.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $13.00K 10-Q · filed 2026-05-12 | $23.00K derived: sum of 2 quarters · filed 2026-05-12 | $23.00K derived: sum of 3 quarters · filed 2026-05-12 | $23.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $10.00K derived: sum of 2 quarters · filed 2026-03-12 | $10.00K derived: sum of 3 quarters · filed 2026-03-12 | $10.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2025-11-12 | $3.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-13 | $0.00 10-Q · filed 2025-08-13 | $3.00K derived: sum of 3 quarters · filed 2025-05-15 | $4.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | $3.00K derived: sum of 2 quarters · filed 2025-05-15 | $4.00K derived: sum of 3 quarters · filed 2025-05-15 | $5.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.00K derived: sum of 2 quarters · filed 2025-03-31 | $5.00K derived: sum of 3 quarters · filed 2025-03-31 | $6.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.00K 10-Q · filed 2024-11-12 | $2.00K derived: sum of 2 quarters · filed 2024-11-12 | $3.00K 10-Q · filed 2024-11-12 | $4.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.00K 10-Q · filed 2024-08-13 | $2.00K 10-Q · filed 2024-08-13 | $3.00K derived: sum of 3 quarters · filed 2024-08-13 | $4.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $1.00K 10-Q · filed 2024-05-10 | $2.00K derived: sum of 2 quarters · filed 2024-05-10 | $3.00K derived: sum of 3 quarters · filed 2024-05-10 | $4.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $2.00K derived: sum of 2 quarters · filed 2024-03-08 | $3.00K derived: sum of 3 quarters · filed 2024-03-08 | $4.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $1.00K 10-Q · filed 2023-11-13 | $2.00K derived: sum of 2 quarters · filed 2023-11-13 | $3.00K 10-Q · filed 2023-11-13 | $4.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.00K 10-Q · filed 2023-08-11 | $2.00K 10-Q · filed 2023-08-11 | $3.00K derived: sum of 3 quarters · filed 2023-08-11 | $4.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-15 | $2.00K derived: sum of 2 quarters · filed 2023-05-15 | $3.00K derived: sum of 3 quarters · filed 2023-05-15 | $4.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $2.00K derived: sum of 2 quarters · filed 2023-03-30 | $3.00K derived: sum of 3 quarters · filed 2023-03-30 | $4.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $1.00K 10-Q · filed 2022-11-04 | $2.00K derived: sum of 2 quarters · filed 2022-11-04 | $3.00K 10-Q · filed 2022-11-04 | $4.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $1.00K 10-Q · filed 2022-08-12 | $2.00K 10-Q · filed 2022-08-12 | $3.00K derived: sum of 3 quarters · filed 2022-08-12 | $4.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $1.00K 10-Q · filed 2022-05-13 | $2.00K derived: sum of 2 quarters · filed 2022-05-13 | $3.00K derived: sum of 3 quarters · filed 2022-05-13 | $4.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $2.00K derived: sum of 2 quarters · filed 2022-03-24 | $3.00K derived: sum of 3 quarters · filed 2022-03-24 | $8.00K 10-K · filed 2022-03-24 |
| 2020-09-30 | $1.00K 10-Q · filed 2021-11-12 | $2.00K derived: sum of 2 quarters · filed 2021-11-12 | $7.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $1.00K 10-Q · filed 2021-08-12 | $6.00K 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | $5.00K 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | $3.00K 10-K · filed 2021-03-11 | |||
| 2015-09-30 | $7.30K 10-Q · filed 2015-11-02 | $13.78K derived: sum of 2 quarters · filed 2015-11-02 | $19.94K 10-Q · filed 2015-11-02 | $25.85K derived: sum of 4 quarters · filed 2015-11-02 |
| 2015-06-30 | $6.48K 10-Q · filed 2015-08-07 | $12.64K 10-Q · filed 2015-08-07 | $18.55K derived: sum of 3 quarters · filed 2015-08-07 | $22.30K derived: sum of 4 quarters · filed 2015-11-02 |
| 2015-03-31 | $6.17K 10-Q · filed 2015-05-08 | $12.07K derived: sum of 2 quarters · filed 2015-05-08 | $15.82K derived: sum of 3 quarters · filed 2015-11-02 | $25.45K derived: sum of 4 quarters · filed 2015-11-02 |
| 2014-12-31 | $5.91K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $9.65K derived: sum of 2 quarters · filed 2015-11-02 | $19.28K derived: sum of 3 quarters · filed 2015-11-02 | $28.32K 10-K · filed 2015-03-16 |
| 2014-09-30 | $3.74K 10-Q · filed 2015-11-02 | $13.37K derived: sum of 2 quarters · filed 2015-11-02 | $22.42K 10-Q · filed 2015-11-02 | $31.36K derived: sum of 4 quarters · filed 2015-11-02 |
| 2014-06-30 | $9.63K 10-Q · filed 2015-08-07 | $18.67K 10-Q · filed 2015-08-07 | $27.61K derived: sum of 3 quarters · filed 2015-08-07 | $37.26K derived: sum of 4 quarters · filed 2015-08-07 |
| 2014-03-31 | $9.04K 10-Q · filed 2015-05-08 | $17.98K derived: sum of 2 quarters · filed 2015-05-08 | $27.63K derived: sum of 3 quarters · filed 2015-05-08 | $36.86K derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $8.94K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $18.58K derived: sum of 2 quarters · filed 2015-03-16 | $27.82K derived: sum of 3 quarters · filed 2015-03-16 | $37.13K 10-K · filed 2015-03-16 |
| 2013-09-30 | $9.64K 10-Q · filed 2014-11-12 | $18.88K derived: sum of 2 quarters · filed 2014-11-12 | $28.20K 10-Q · filed 2014-11-12 | $38.42K derived: sum of 4 quarters · filed 2014-11-12 |
| 2013-06-30 | $9.23K 10-Q · filed 2014-08-13 | $18.55K 10-Q · filed 2014-08-13 | $28.77K derived: sum of 3 quarters · filed 2014-08-13 | $39.49K derived: sum of 4 quarters · filed 2014-08-13 |
| 2013-03-31 | $9.32K 10-Q · filed 2014-05-14 | $19.54K derived: sum of 2 quarters · filed 2014-05-14 | $30.26K derived: sum of 3 quarters · filed 2014-05-14 | $40.98K derived: sum of 4 quarters · filed 2014-05-14 |
| 2012-12-31 | $10.22K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $20.94K derived: sum of 2 quarters · filed 2014-03-21 | $31.66K derived: sum of 3 quarters · filed 2014-03-21 | $42.39K 10-K · filed 2014-03-21 |
| 2012-09-30 | $10.72K 10-Q · filed 2013-11-13 | $21.44K derived: sum of 2 quarters · filed 2013-11-13 | $32.16K 10-Q · filed 2013-11-13 | $42.33K derived: sum of 4 quarters · filed 2013-11-13 |
| 2012-06-30 | $10.72K 10-Q · filed 2013-08-12 | $21.44K 10-Q · filed 2013-08-12 | $31.61K derived: sum of 3 quarters · filed 2013-08-12 | $41.73K derived: sum of 4 quarters · filed 2013-08-12 |
| 2012-03-31 | $10.72K 10-Q · filed 2013-05-09 | $20.89K derived: sum of 2 quarters · filed 2013-05-09 | $31.01K derived: sum of 3 quarters · filed 2013-05-09 | $41.66K derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $10.17K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | $20.29K derived: sum of 2 quarters · filed 2013-03-22 | $30.94K derived: sum of 3 quarters · filed 2013-03-22 | $45.07K 10-K · filed 2013-03-22 |
| 2011-09-30 | $10.13K 10-Q · filed 2012-11-08 | $20.78K derived: sum of 2 quarters · filed 2012-11-08 | $34.90K 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $10.65K 10-Q · filed 2012-08-08 | $24.78K 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |